santa cruz biotechnology, inc.
SCBT Logo

Willkommen!        Produkt(e) im Warenkorb.     Bestellen
 

Cannabinoids

  • 1,3-bis(4-Bromophenyl)-5-phenyl-2,4-imidazolidinedione
    An imidazolidine-2,-4-dione derivative that is an effective and selective inverse agonist of CB cannabinoid receptor.
    Katalog #CAS NummerSummenformelMenge
    sc-202872878533-35-8C21H14Br2N2O25 mg
  • 2-(14,15-Epoxyeicosatrienoyl) Glycerol
    This product is an endogenous central cannabinoid (CB1) receptor agonist and increases DNA synthesis in LLCPKcl4 cells.
    Katalog #CAS NummerSummenformelMenge
    sc-205073848667-56-1C23H38O525 µg/50 µg
  • 2-[(3-chlorophenyl)methyl]-5-hydroxy-1H-benz[g]indole-3-carboxylic acid, ethyl ester
    A potent, reversible inhibitor of 5-LO, both in cell-free assays (IC50 = 86 nM) and in intact neutrophils (IC50 = 230 nM).
    Katalog #CAS NummerSummenformelMenge
    sc-2876391159576-98-3C22H18ClNO31 mg/5 mg
  • 2-Palmitoylglycerol
    A fatty acid ester, which increases the ability of 2-arachidonoylglycerol to bind to CB1 and CB2 cannabinoid receptors.
    Katalog #CAS NummerSummenformelMenge
    sc-20346523470-00-0C19H38O410 mg
  • 3-decyl-5,5'-diphenyl-2-thioxo-4-imidazolidinone
    A reversible competitive inhibitor of FAAH activity exhibiting an IC50value of 1.3 µM. Has no affinity for the human CB1 receptor and acts as a competitive inhibitor of FAAH activity without being hydrolyzed by the enzyme.
    Katalog #CAS NummerSummenformelMenge
    sc-204619875014-22-5C25H32N2OS500 µg/1 mg
  • 7(Z),11(Z)-Pentacosadiene
    Unsaturated, long-chain hydrocarbons are found on the cuticles of insects and can act as pheromones. In mature Drosophila melanogaster, certain cuticular hydrocarbons are sexually dimorphic: males synthesize 23- and 25-C monoenes and females produce 27- and 29-C dienes. Each of these lipids plays specific roles in regulating male sexual behavior, with dienes stimulating courtship. 7(Z),11(Z)-Pentacosadiene is a 25-C hydrocarbon that is found in low abundance on cuticles of mature Drosophila females. Depletion of a female-specific elongase (eloF), which leads to an increase in 7(Z),11(Z)-pentacosadiene along with a parallel decrease in 7,11-nonacosadiene, significantly reduces copulation in Drosophila. This raises the possibility that 7(Z),11(Z)-pentacosadiene may act as an anti-aphrodisiac.
    Katalog #CAS NummerSummenformelMenge
    sc-291656127599-39-7C25H481 mg/5 mg
  • 8-iso Prostaglandin F2α Ethanolamide
    Its been reported that anandamide (AEA) can be used directly by cyclooxygenase-2 and specific prostaglandin H2 (PGH2) isomerases to produce ethanolamide congeners of the classical PGs, including PGF2α. PGF2α ethanolamide has also been reported to be biosynthesized by this mechanism when AEA was infused into the lung and liver of fatty acid amide hydrolase-deficient mice. The accumulation of AEA can also lead to isoprostane-type peroxidative decomposition. 8-iso PGF2α ethanolamide is a standard that allows one to distinguish these non-enzymatic decomposition products from “prostamides” that possible have enzymatic origin.
    Katalog #CAS NummerSummenformelMenge
    sc-221140n.n.C22H39NO5100 µg/500 µg
  • ABN-CBD
    Neurobehaviorally inactive cannabinoid that acts as a selective agonist for GPR55 (EC50 values are 2.5, >30 and >30 μM at GPR55, CB1 and CB2 receptors respectively). Increases the phosphorylation of protein kinases in, and migration of, human umbilical vein endothelial cells.
    Katalog #CAS NummerSummenformelMenge
    sc-20348822972-55-0C21H30O210 mg
  • Abnormal Cannabidiol-d3
    Contains three deuterium atoms at the terminal methyl position. Intended for use as an internal standard for the quantification of compound by GC- or LC-mass spectrometry. A synthetic regioisomer of cannabidiol that fails to elicit either CB1 or CB2 responsiveness and is without psychotropic activity. Induces endothelium-dependent vasodilation via a CB1/CB2/nitric oxide-independent mechanism. Showed hypotensive activity that could not be antagonized by cannabidiol or SR141716A. Compound is therefore believed to activate a third type of CB receptor, provisionally called the non-CB1/CB2 endocannabinoid receptor. Also acts via these receptors to regulate the migratory activity of murine BV-2 microglial cells, with an EC50 value of 600 nM.
    Katalog #CAS NummerSummenformelMenge
    sc-223766n.n.C21H30D3O2100 µg/500 µg
  • ACEA
    A compound that can bind to CB1 receptors with a high affinity of Ki =1.4nM and acts as a potent and selective agonist of the CB1 receptors.
    Katalog #CAS NummerSummenformelMenge
    sc-202902220556-69-4C22H36ClNO5 mg
  • Allopregnanolone
    Progesterone metabolite devoid of any progestational activity. Acts as a potent ligand of GABA-mediated Cl uptake in synaptosomes more effectively (100- to 1,000-fold) than benzodiazepines or barbituates. In dose-dependent manner, causes a raid increase in Ca2+ influx.
    Katalog #CAS NummerSummenformelMenge
    sc-203813516-54-1C21H34O210 mg
  • α-Linolenoyl Ethanolamide
    α-Linolenoyl ethanolamide is an endocannabinoid containing α-linolenic acid in place of the arachidonate moiety of AEA. It has been detected in porcine brain, but its relative importance and specific role as a cannabinergic neurotransmitter have not been elucidated.
    Katalog #CAS NummerSummenformelMenge
    sc-22376357086-93-8C20H35NO25 mg/10 mg
  • AM 281
    Analog of the cannabinoid receptor (CB) antagonist SR 141716A. Potent CB1 receptor antagonist/inverse agonist (Ki=14nM).
    Katalog #CAS NummerSummenformelMenge
    sc-202050202463-68-1C21H19Cl2IN4O21 mg/5 mg
  • AM-251
    A 123I radioisotope derivative of the CB1 cannabinoid receptor inverse agonist SR141716A. Demonstrates a strong affinity (Ki = 7.49 nM) for CB1. A radioprobe for CB1-ligand binding studies.
    Katalog #CAS NummerSummenformelMenge
    sc-200366183232-66-8C22H21Cl2IN4O10 mg/1 mg/50 mg
  • AM-404
    Anandamide is an endocannabinoid transport inhibitor, which does not activate cannabinoid receptors or inhibit anandamide amidase.
    Katalog #CAS NummerSummenformelMenge
    sc-200363198022-70-7C26H37NO210 mg/50 mg
  • AM-630
    A potentially useful cannabinoid receptor antagonist selective for CB1 and CB2.
    Katalog #CAS NummerSummenformelMenge
    sc-200365164178-33-0C23H25IN2O310 mg
  • Arachidonamide (20:4, n-6)
    A weak cannabinoid CB1 and CB2 agonist 1.
    Katalog #CAS NummerSummenformelMenge
    sc-22125885146-53-8C20H33NO10 mg/50 mg
  • Arachidonoyl 2'-fluoroethylamide
    CB1 receptor agonist (CB1: Ki=26.7nM; CB2: Ki=908nM).
    Katalog #CAS NummerSummenformelMenge
    sc-202469166100-37-4C22H36NOF5 mg
  • Arachidonoyl p-Nitroaniline
    A relatively unselective enzyme that accepts a variety of amide head groups other than the ethanolamine of its nominal endogenous substrate AEA.
    Katalog #CAS NummerSummenformelMenge
    sc-205211119520-58-0C26H36N2O31 g/10 g
  • Arachidonoyl-1-thio-Glycerol
    2-Arachidonoyl glycerol (2-AG) is an endogenous agonist of the central cannabinoid (CB1) receptor. It is present at relatively high levels in the central nervous system and is the most abundant molecular species of monoacylglycerol found in rat brain. Monoacylglycerol lipase (MGL) hydrolyzes 2-AG to arachidonic acid and glycerol, thereby terminating its biological actions. Arachidonoyl-1-thio-glycerol is a thioester substrate analog of 2-AG that can be utilized for the measurement of MGL activity. Hydrolysis of the thioester bond by MGL generates a free thiol that reacts rapidly with the chromogenic reagent DTNB (Ellman’s reagent) resulting a yellow product with an absorbance maximum at 412 nm.
    Katalog #CAS NummerSummenformelMenge
    sc-221265n.n.C23H38O3S1 mg/5 mg
  • Arachidonoyl-AMC
    A fluorogenic substrate for fatty acid amide hydrolase (FAAH)1. This substrate is the basis for a simple, selective and sensitive assay for FAAH which is amenable to high-throughput screening.
    Katalog #CAS NummerSummenformelMenge
    sc-223784n.n.C30H39NO35 mg/25 mg
  • Arachidonoyl-N-methyl amide
    Binds to the human central cannabinoid receptor with a Ki of 60 nM; inhibits rat glial gap junction cell-cell communication.
    Katalog #CAS NummerSummenformelMenge
    sc-205212156910-29-1C21H35NO5 mg/10 mg
  • Arachidonylcyclopropylamide (ACPA)
    ACPA is an N-arachidonylethanolamine analog and a selective cannabinoid CB1 receptor.
    Katalog #CAS NummerSummenformelMenge
    sc-200795229021-64-1C23H37NO10 mg/50 mg
  • AVE-1625
    The central cannabinoid (CB1) receptor is a G protein-coupled receptor that is widespread in the central nervous system and several peripheral tissues and binds the active component of cannabis, Δ9-tetrahydrocannabinol. Signaling through the CB1 receptor is involved in attentional and working memory deficits as well as obesity. AVE-1625 is a selective, highly potent antagonist for the CB1 receptor with Ki values of 0.16-0.44 nM. At 1-3 mg/kg, AVE-1625 significantly enhances the performance of rodents in working memory tasks. At 30 mg/kg, AVE-1625 reduces caloric intake by more than 50% of controls, reduces hepatic glycogen levels in rodents and significantly increases lipolysis from fat tissues.
    Katalog #CAS NummerSummenformelMenge
    sc-221277358970-97-5C23H20Cl2F2N2O2S1 mg/5 mg
  • Bay 59-3074
    Katalog #CAS NummerSummenformelMenge
    sc-361118406205-74-1C18H13F6NO4S10 mg/50 mg
  • BML-190
    An indomethacin morpholinylamide which functions as a selective inverse agonist of the human cannabinoid CB2 receptor.
    Katalog #CAS NummerSummenformelMenge
    sc-2035332854-32-2C23H23ClN2O410 mg/50 mg
  • CAY10448
    An iodinated nonivamide, a potent capsaicin receptor antagonist with an IC50 of approximately 10 nM.
    Katalog #CAS NummerSummenformelMenge
    sc-223862n.n.C18H28INO31 mg/5 mg
  • CB 13
    Potent, orally active CB1/CB2 receptor agonist with limited brain penetration (EC50 values are 6.1 and 27.9 nM for CB1 and CB2 receptors respectively).
    Katalog #CAS NummerSummenformelMenge
    sc-203870432047-72-8C26H24O210 mg/50 mg
  • CB 65
    Katalog #CAS NummerSummenformelMenge
    sc-361134n.n.C22H28ClN3O310 mg/50 mg
  • CB-52
    A stable analog of Δ9-tetrahydrocannabinol (THC) and anandamide (AEA) which exhibits high affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptor with Ki values of 210 and 30 nM, respectively. This compound behaves primarily as a CB1 receptor partial agonist and a CB2 receptor neutral antagonist in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-221404n.n.C26H43NO31 mg/5 mg
  • CB-86
    A resorcinol-anandamide hybrid compound that acts as a partial agonist for the central cannabinoid (CB1) receptor and a neutral antagonist for the peripheral cannabinoid (CB2) receptor.
    Katalog #CAS NummerSummenformelMenge
    sc-2939871150586-64-3C26H43NO31 mg/5 mg
  • CB-25
    CB-25 is a stable analog of anandamide (AEA) and Δ9-tetrahydrocannabinol (THC). It exhibits high affinity for the central cannabinoid (CB1) and peripheral cannabinoid (CB2) receptors with Ki values of 5.2 and 13 nM, respectively. CB-25 behaves as an inverse agonist for the CB1 receptor as assessed in a cyclic AMP (cAMP) functional assay.
    Katalog #CAS NummerSummenformelMenge
    sc-204675869376-63-6C25H41NO31 mg/5 mg
  • Copper(II) Protoporphyrin IX (free acid)
    A negative control for the heme oxygenase inhibitor, zinc protoporphyrin IX.
    Katalog #CAS NummerSummenformelMenge
    sc-205935n.n.C34H32CuN4O425 mg
  • CP-55,940
    A cannabimimetic and potent cannabinoid receptor agonist. Demonstrates similar affinity at CB1 and CB2 (CB1 Ki=0.58 nM, CB2 Ki=0.69 nM).
    Katalog #CAS NummerSummenformelMenge
    sc-20035983002-04-4C24H40O35 mg/25 mg
  • CP 945598 hydrochloride
    Katalog #CAS NummerSummenformelMenge
    sc-361159686347-12-6C25H25Cl2N7O•HCl10 mg/50 mg
  • DEA
    Potent endocannabinoid (anandamide analog) that activates CB1 receptors in microglia and binds to rat synaptosomal membranes.
    Katalog #CAS NummerSummenformelMenge
    sc-203024150314-35-5C24H41NO25 mg
  • Decanoyl-p-nitroanilide
    A fatty acid amide used as a probe for FAAH activity. Processing by FAAH releases an equivalent of p-nitroaniline which can be assayed with UV-Vis (382 nm, ε = 13500 M-1cm-1).
    Katalog #CAS NummerSummenformelMenge
    sc-20142972298-63-6C16H24N2O320 mg/100 mg
  • Dihomo-γ-linolenylethanolamide
    Endocannabinoid. Binds to recombinant human CB1 (Ki=857nM) and CB2 receptor (Ki=598nM). Also inhibits adenylyl cyclase (IC50=109nM).
    Katalog #CAS NummerSummenformelMenge
    sc-202137150314-34-4C22H39NO25 mg
  • Docosahexaenoyl Ethanolamide
    Docosahexaenoic Acid (DHA) is an essential fatty acid and the most abundant ω-3 fatty acid in neural tissues, particularly in the retina and brain. Docosahexaenoyl ethanolamide (DHEA) is an ethanolamine amide of DHA that has been detected in both retina and brain at concentrations similar to those for arachidonoyl ethanolamide (AEA). A 9.5 fold increase of DHEA was observed in brain lipid extracts from piglets on a DHA-supplemented diet compared to a DHA-free control diet. DHEA binds rat brain CB1 receptor with a Kι of 324 nM, which is about 10-fold higher than the Kι for AEA. DHEA inhibits shaker-related voltage-gated potassium channels in the brain slightly better than AEA, with an IC50 of 1.5 µM.
    Katalog #CAS NummerSummenformelMenge
    sc-221563162758-94-3C24H37NO25 mg/10 mg
  • Ethyl Ferulate
    Induces heme oxygenase-1 and protects rat neurons against oxidative stress. Protects neurons against amyloid β peptide (1-42)-induced oxidative stress and neurotoxicity.
    Katalog #CAS NummerSummenformelMenge
    sc-2008234046-02-0C12H14O4100 mg
  • Fluprostenol serinol amide
    A stable analog of PGF2α 2-glyceryl ester that has much greater stability. The biological activity of Flu-SA has not yet been determined.
    Katalog #CAS NummerSummenformelMenge
    sc-221620n.n.C26H36F3NO71 mg/5 mg
  • Glycerophospho-N-Oleoyl Ethanolamine
    N-Acylated ethanolamines (NAE) are naturally-occurring lipids with diverse bioactivities. For example, arachidonoyl ethanolamide (AEA) is an endogenous cannabinoid neurotransmitter that evokes cellular responses by activating the cannabinoid receptors, peripheral cannabinoid (CB2) and central cannabinoid (CB1). The different types of NAE are derived from glycerophospho-linked precursors by the activity of glycerophosphodiesterase 1 (GDE1). Glycerophospho-N-oleoyl ethanolamine is the precursor of oleoyl ethanolamide (OEA). OEA is an potent, endogenous agonist for PPARα, exhibiting an EC50 value of 120 nM in a transactivation assay. Systemic administration of OEA suppresses food intake and reduces weight gain in rats (10 mg/kg intraperitoneally) and PPARα wild-type mice, but not in PPARα knockout mice. Like AEA, OEA is metabolized by fatty acid amide hydrolase (FAAH).
    Katalog #CAS NummerSummenformelMenge
    sc-224008201738-24-1C23H46NO7P1 mg/5 mg
  • Glycerophospho-N-Palmitoyl Ethanolamine
    N-Acylated ethanolamines (NAE) are naturally-occurring lipids that have diverse bioactivities.
    Katalog #CAS NummerSummenformelMenge
    sc-224009100575-09-5C21H44NO7P1 mg/5 mg
  • GP 1a
    Highly selective CB2 agonist receptor; Ki values are 0.037 and 363 nM for CB2 and CB1 receptors respectively. Increases P-ERK1/2 expression in HL-60 cells in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-203980n.n.C23H22Cl2N4O10 mg/50 mg
  • GP 2A
    Selective CB2 receptor agonist; Ki values are 7.6 and 900 nM for CB2 and CB1 receptors respectively. Increases P-ERK1/2 expression in HL-60 cells in vitro.
    Katalog #CAS NummerSummenformelMenge
    sc-203588919077-81-9C24H23Cl2N3O10 mg/50 mg
  • GW-405833
    GW-405833 binds to both rat and human CB2 receptors where it acts as a partial agonist.
    Katalog #CAS NummerSummenformelMenge
    sc-200373180002-83-9C23H24Cl2N2O310 mg/50 mg
  • GW 842166X
    A CB2 receptor agonist with ED50 values of 91 and 63 nM in rat and human, respectively.2 When administered orally to rats in the Freund’s complete adjuvant (FCA) model of inflammatory pain, GW 842166X is highly potent with an ED50 value of 0.1 mg/kg and full reversal of hyperalgesia at 0.3 mg/kg.2
    Katalog #CAS NummerSummenformelMenge
    sc-205338666260-75-9C18H17Cl2F3N4O21 mg/5 mg
  • HU-331
    A hydroxylquinone cannabidiol analog that exhibits potent antineoplastic activity on a variety of human cancer cell lines.
    Katalog #CAS NummerSummenformelMenge
    sc-205345137252-25-6C21H28O3500 µg/5 mg
  • JNJ 1661010
    Selective and reversible inhibitor of fatty acid amide hydrolase (FAAH) (IC50 = 12nM). Brain penetrant and active in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-204023681136-29-8C19H19N5OS10 mg/50 mg
  • JTE 907
    Highly selective cannabinoid CB2 receptor inverse agonist. Binds with high affinity to rat, mouse and human CB2 receptors (Ki values are 0.38, 1.55 and 35.9 nM respectively). Produces anti-inflammatory effects in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-203616282089-49-0C24H26N2O610 mg/50 mg
  • L-759633
    High affinity, selective CB2 receptor agonist. Potently inhibits forskolin-stimulated cAMP production via CB2 receptors expressed in CHO cells.
    Katalog #CAS NummerSummenformelMenge
    sc-203438174627-50-0C26H40O210 mg
  • Leelamine HCl
    A weak agonist of the CB1 receptor. Inhibits PDK activity.
    Katalog #CAS NummerSummenformelMenge
    sc-2003751446-61-3C20H31N··HCl10 mg/50 mg
  • Linoleamide
    Unsaturated analog of endogenous sleep-inducing lipid.
    Katalog #CAS NummerSummenformelMenge
    sc-221852n.n.C18H33NO10 mg/50 mg
  • Linoleylethanolamide
    Endocannabinoid. Does also bind to TRPV1 (Ki=5.60µM).
    Katalog #CAS NummerSummenformelMenge
    sc-20310768171-52-8C20H37NO210 mg
  • LY-320135
    Potent and selective Canniboid CB1 receptor antagonist/inverse agonist. Selective (~70 fold) over Canniboid CB2 receptors.
    Katalog #CAS NummerSummenformelMenge
    sc-204066176977-56-3C24H17NO4•xH2O10 mg/50 mg
  • MAFP
    An irreversible inhibitor of cytosolic phospholipase As that also potently inhibits anandamide amidohydrolase and phosphorylates arachidonyl binding sites.
    Katalog #CAS NummerSummenformelMenge
    sc-203440188404-10-6C21H36FO2P5 mg
  • MDA 19
    Katalog #CAS NummerSummenformelMenge
    sc-3588041048973-47-2C21H23N3O21mg/5mg
  • Mead acid ethanolamide
    A cannabinoid CB1 and CB2 agonist equipotent with anandamide1.
    Katalog #CAS NummerSummenformelMenge
    sc-202704169232-04-6C22H39NO21 mg/10 mg
  • MJ 15
    Katalog #CAS NummerSummenformelMenge
    sc-361252944154-76-1C23H17Cl3N4O10 mg/50 mg
  • N-(3-hydroxyphenyl)-Arachidonoyl amide
    An analog of AM404, which is a selective inhibitor of carrier-mediated transport of AEA. 3-HPA is metabolized by both COX-1 and COX-2 and was found to selectively and irreversibly inhibit COX-2 with an IC50 value of 2 µM.
    Katalog #CAS NummerSummenformelMenge
    sc-221969183718-75-4C26H37NO25 mg/10 mg
  • N-Arachidonoyl glycine
    Katalog #CAS NummerSummenformelMenge
    sc-362169179113-91-8C22H35NO35 mg
  • N-Arachidonoyl glycine (solution in ethanol)
    Endogenous anandamide-like compound. Lacks affinity for CB1 receptors (Ki>10µM), TRPV1 (EC50>10µM) and anandamide uptake (IC550>50µM), but inhibits fatty acid amide hydrolase (FAAH) (IC50=8.5µM-50µM, depending on cell type and species).
    Katalog #CAS NummerSummenformelMenge
    sc-203149179113-91-8C22H35NO35 mg
  • N-Arachidonoyl phosphatidylethanolamine
    N-arachidonoyl phosphatidylethanolamine (NAPE) is a precursor in anandamide (AEA) biosynthesis via multiple pathways. NAPE can be cleaved by a phospholipase D yielding phosphatidic acid and AEA. On the other hand, in macrophages NAPE is cleaved by a phospholipase C yielding phosphoanandamide (pAEA). A phosphatase, PTPN22 is one enzyme that cleaves pAEA leading to the generation of anandamide. Another pathway proceeds via double deacylation of NAPE generating glycerophospho-NAE. Phosphodiesterase-mediated cleavage of this intermediate yields anandamide.
    Katalog #CAS NummerSummenformelMenge
    sc-221989n.n.C57H104NO4P1 mg/5 mg
  • N-Arachidonoyl-(L)-alanine (NA-Ala)
    One member of a new class of lipoamino acids related to anandamide identified in bovine brain.
    Katalog #CAS NummerSummenformelMenge
    sc-221991n.n.C23H37NO35 mg/25 mg
  • N-Arachidonoyl-GABA (NA-GABA)
    One member of a new class of lipoamino acids related to anandamide identified in bovine brain1. Displays analgesic activity1,2.
    Katalog #CAS NummerSummenformelMenge
    sc-221992128201-89-8C24H39NO35 mg/25 mg
  • N-Arachidonoyl-L-serine
    Endocannabinoid-like brain constituent with similar biological profile to abnormal cannabidiol. Binds weakly to CB1 and CB2 receptors and TRPV1. Produces endothelium-dependent vasodilation.
    Katalog #CAS NummerSummenformelMenge
    sc-202718187224-29-9C23H37NO410 mg
  • N-Linoleoylglycine
    Possible endogenous LA metabolite and 18:2 anandamide metabolite. May display antinflamatory activity.
    Katalog #CAS NummerSummenformelMenge
    sc-2057612764-03-6C20H35NO35 mg/25 mg
  • N-Oleoyl-L-serine
    N-Oleoylserine was isolated from mouse trabecular bone and brain and was determined to be the L-isomer. It was shown to promote the proliferation and growth of MC3T3 E1 osteoblasts at 10-11M via a pertusis toxin-sensitive mechanism and transiently induced ERK1/2 phosphorylation. It inhibited osteoclast formation in vitro and in an ovariectomy-induced bone loss model, it induced complete rescue after 12 weeks (5mg/kg)1.
    Katalog #CAS NummerSummenformelMenge
    sc-222013n.n.C21H39NO45 mg/25 mg
  • NESS 0327
    NESS 0327 is an extremely potent cannabinoid receptor antagonist with high selectivity for the CB1 receptor compared to the CB2 receptor with Ki values of 0.35 pM and 21 nM, respectively. It is a much more potent antagonist and more selective for the CB1 receptor compared to SR 141716A. At nM concentrations NESS 0327 competitively inhibits the binding of the synthetic CB agonist WIN 55,212-2 in isolated rat cerebella membranes and murine vas deferens. Unlike SR 141716A, NESS 0327 at higher doses does not act as a CB1 receptor inverse agonist and does not produce any physiological effects of its own.
    Katalog #CAS NummerSummenformelMenge
    sc-222054494844-07-4C24H23Cl3N4O1 mg/5 mg
  • NS309
    A Ca2+ -activated IK/SK potassium channel activator.
    Katalog #CAS NummerSummenformelMenge
    sc-25320218711-16-5C8H4Cl2N2O25 mg
  • O-1602
    An analog of cannabidiol and activator of the novel endocannabinoid receptor GRP55. Vasodilation is produced independent of GRP55 activation and independent of the CB1/CB2 receptors.
    Katalog #CAS NummerSummenformelMenge
    sc-202745317321-41-8C17H22O21 mg/5 mg
  • O-1821
    O-1821 is a cannabidiol analog with close structural similarity to O-1918 which is a selective antagonist of abnormal cannabidiol at the non-CB1/CB2 endothelial receptor.2 O-1918 does not bind to CB1 or CB2 receptors at concentrations up to 30 µM and inhibits the vasorelaxant effects of abnormal cannabidiol in vitro and in whole animals.2 The biological activity of O-1821 has not been reported.
    Katalog #CAS NummerSummenformelMenge
    sc-20541735482-50-9C17H22O21 mg/5 mg
  • O-1918
    Analog of cannabidiol. Antagonist of the endothelial non-CB1/CB2 cannabinoid receptor. Induces endothelium-dependent vasodilation via a CB1/CB2/nitric oxide-independent mechanism.
    Katalog #CAS NummerSummenformelMenge
    sc-202746536697-79-7C19H26O21 mg/5 mg
  • O-2093
    Katalog #CAS NummerSummenformelMenge
    sc-361283n.n.C34H43Cl2NO35 mg/25 mg
  • O-Arachidonoyl Glycidol
    An endogenous ligand that binds to both central cannabinoid and peripheral cannabinoid receptors; inhibits fatty acid amide hydrolase-catalyzed hydrolysis of arachidonoyl ethanolamide.
    Katalog #CAS NummerSummenformelMenge
    sc-222087439146-24-4C23H36O35 mg/10 mg
  • Oleoyl Ethanolamide-d2
    Contains two deuterium atoms at the 11 position. It is intended for use as an internal standard for the quantification of OEA by GC- or LC-mass spectrometry.
    Katalog #CAS NummerSummenformelMenge
    sc-222098111-58-0 (unlabeled)C20H37D2NO2100 µg/500 µg
  • Oleoyl Ethanolamide-d4
    Oleoyl ethanolamide (OEA) is an analog of the endocannabinoid AEA found in brain tissue and in chocolate. It is one of the long chain fatty acid ethanolamides that accumulates rapidly in infarcted tissue but its biosynthesis is reduced in the intestine of rats following food deprivation. OEA is an endogenous, potent agonist for PPARα, exhibiting an EC50 value of 120 nM in a transactivation assay. Systemic administration of OEA suppresses food intake and reduces weight gain in rats (10 mg/kg intraperitoneally) and PPARα wild-type mice, but not in PPARα knockout mice. These data indicate that OEA regulates food intake by a PPARα-mediated mechanism.
    Katalog #CAS NummerSummenformelMenge
    sc-295976n.n.C20H35D4NO2100 µg/500 µg
  • Palmitoyl Ethanolamide-d5
    A labeled form of an endogenous cannabinoid found in brain, liver, and other mammalian tissues.
    Katalog #CAS NummerSummenformelMenge
    sc-296022n.n.C18H32D5NO2500 µg/1 mg
  • Palmitoyl-N-isopropylamide
    An inhibitor of the FAAH (fatty acid amide hydrolase). Palmitoyl-N-isopropylamide functions similarly to AM-404 (sc-200363) in inhibiting the formation of [3H]-ethanolamine from [3H]-AEA.
    Katalog #CAS NummerSummenformelMenge
    sc-203177189939-61-5C19H39NO5 mg
  • Palmitoylethanolamide
    This product is an endogenous cannabinoid. It is a weak ligand of the cannabinoid 1 (CB1) and cannabinoid 2 (CB2) receptors.
    Katalog #CAS NummerSummenformelMenge
    sc-202754544-31-0C18H37NO210 mg/50 mg
  • Petromyzonol
    A tetrahydroxy stearol which serves as the primary spawning pheromone in adult sea lamprey.
    Katalog #CAS NummerSummenformelMenge
    sc-20543028979-29-5C24H42O41 mg/5 mg
  • PF 750
    Irreversible fatty acid amide hydrolase (FAAH) inhibitor (IC50 = 16.2 nM) that displays no activity at a range of other serine hydrolases. Orally active and selectively inhibits FAAH within the central nervous system.
    Katalog #CAS NummerSummenformelMenge
    sc-204181959151-50-9C22H23N3O10 mg/50 mg
  • PF 514273
    Katalog #CAS NummerSummenformelMenge
    sc-361289851728-60-4C21H17Cl2F2N3O210 mg/50 mg
  • PF-622
    Is a potent, irreversible, time-dependent FAAH inhibitor with IC50 values 0.99 and 0.033 µM when preincubated with human recombinant FAAH for 5 and 60 minutes, respectively. Activity-based profiling of various human and murine tissue proteome samples showed that it is highly selective for FAAH relative to other serine hydrolases, showing no discernable off-site activity up to 500 µM.
    Katalog #CAS NummerSummenformelMenge
    sc-205431898235-65-9C21H22N4O1 mg/5 mg
  • Pravadoline
    A cannabimimetic aminoalkylindole. Cannabinoid receptor agonist. Inhibits COX activity.
    Katalog #CAS NummerSummenformelMenge
    sc-20036992623-83-1C23H26N2O35 mg/25 mg
  • (R)-Methanandamide
    A derivative of Anandamide with higher affinity at the CB1 receptor (Ki = 20 nM) than Anandamide itself (Ki =78 nM). Relatively stable to aminopeptidase hydrolysis.
    Katalog #CAS NummerSummenformelMenge
    sc-200792157182-49-5C23H39NO25 mg/25 mg
  • Rimonabant
    Selective central cannabinoid (CB1) receptor inverse agonist used as an appetite suppressant and anti-obesity drug.
    Katalog #CAS NummerSummenformelMenge
    sc-205491168273-06-1C22H21Cl3N4O5 mg/10 mg
  • (±)-SLV 319
    (±)-SLV 319 is the mixture of the CB1 receptor antagonist SLV 319 and its distomer, SLV 319 (+)-enantiomer. SLV 319 is a potent and selective CB1 receptor antagonist with Ki values of 7.8 and 7,943 nM for CB1 and CB2, respectively. SLV 319 is less lipophilic and therefore more water soluble than other known CB1 receptor ligands.
    Katalog #CAS NummerSummenformelMenge
    sc-222317362519-49-1C23H20Cl2N4O2S1 mg/5 mg
  • (S)-SLV 319
    Central cannabinoid receptor antagonists may have potential in the treatment of a number of diseases such as neuro-inflammatory disorders, cognitive disorders, septic shock, obesity, psychosis, addiction, and gastrointestinal disorders. (S)-SLV 319 is a strong and selective CB1 receptor antagonist with Ki values of 7.8 and 7,943 nM for CB1 and CB2, respectively. (S)-SLV 319 is less lipophilic and therefore more water soluble than other known CB1 receptor ligands.
    Katalog #CAS NummerSummenformelMenge
    sc-222285464213-10-3C23H20Cl2N4O2S1 mg/5 mg
  • SER 601
    A potent and selective CB2 receptor agonist (Ki values are 6.3 nM and 1.2 μM for CB2 and CB1 receptors respectively). Has been shown to display analgesic activity in the formalin test in mice.
    Katalog #CAS NummerSummenformelMenge
    sc-296379n.n.C28H38N2O210 mg/50 mg
  • RVD-Hpα
    Katalog #CAS NummerSummenformelMenge
    sc-361323n.n.C65H105N19O171 mg
  • SR 144528
    A selective peripheral cannabinoid receptor inverse agonist; antagonizes the inhibitory effects of CP 55,940.
    Katalog #CAS NummerSummenformelMenge
    sc-224292192703-06-3C29H34ClN3O5 mg/10 mg
  • Tocrifluor T1117
    Katalog #CAS NummerSummenformelMenge
    sc-361385n.n.C56H53Cl2N7O5100 µg
  • trans-EKODE-(E)-Ib
    During oxidative stress, the abundant unsaturated fatty acid linoleic acid undergoes lipid peroxidation to produce α,β-unsaturated epoxy-keto-octadecenoic acids (EKODEs). Nonenzymatic autooxidation of linoleic acid generates six major EKODE isomers, which differ from one another in the positioning and the orientation of the epoxy group relative to the keto moiety. trans-EKODE-(E)-Ib is a biologically active peroxidation product of linoleic acid that is characterized, structurally, by having a trans carbon-carbon double bond between the 9-keto and 12,13-epoxy groups. It activates an antioxidant response element (ARE) in neuronal cells and induces the expression of ARE-regulated cytoprotective genes like NQO1. This EKODE also stimulates the synthesis of aldosterone and corticosterone in adrenal cells when supplied at 1-5 μM. This effect appears to be mediated by a rise in intracellular calcium.
    Katalog #CAS NummerSummenformelMenge
    sc-296585478931-82-7C18H30O425 µg/50 µg
  • UCM 707
    Potent and selective anandamide uptake inhibitor. Potentiates hypokinetic and antinociceptive effects of anandamide in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-203308390824-20-1C25H37NO25 mg
  • URB447
    URB447 is a mixed central cannabinoid (CB1) receptor antagonist/peripheral cannabinoid (CB2) receptor agonist with IC50 values of 313 and 41 nM, respectively. At 20 mg/kg delivered intraperitoneally to ob/ob mice and Swiss mice, URB447 reduces food intake and body-weight gain with an efficacy comparable to rimonabant,1 which is an inverse agonist for the CB1. Marketed as an anti-obesity drug and appetite suppressant, rimonabant was subsequently suspended from distribution due to serious psychiatric side effects attributed to its indiscriminate activity on CB1 receptors in the central nervous system (CNS). Unlike rimonabant, URB447 does not penetrate the blood brain barrier (to antagonize CB1 receptors in the CNS); instead, it appears to selectively block peripheral CB1 receptors such as those located in the gastrointestinal tract.
    Katalog #CAS NummerSummenformelMenge
    sc-2243471132922-57-6C25H21ClN2O5 mg/10 mg
  • VDM-11
    A selective inhibitor of the anandamide membrane transporter, blocking reuptake of the endocannabinoid anandamide. Shows no agonism of the TRPV1 receptor.
    Katalog #CAS NummerSummenformelMenge
    sc-200371313998-81-1C27H39NO210 mg/50 mg
  • Virodhamine
    Endogenous cannabinoid receptor mixed antagonist/agonist found in higher concentrations peripherally than anandamide. Full agonist at GPR55 and CB2 and partial antagonist/agonist at CB1 (EC50 values are 12, 381 and 2920 nM at GPR55, CB2 and CB1 receptors respectively). Induces hypothermia in vivo.
    Katalog #CAS NummerSummenformelMenge
    sc-204383287937-12-6C22H37NO25 mg/25 mg
  • Virodhamine hydrochloride
    Partial agonist with in vivo antagonist activity at the CB1 receptor (EC50=1.9µM; 61% efficacy), full agonist for the CB2 receptor (100% efficacy).
    Katalog #CAS NummerSummenformelMenge
    sc-202853443129-35-9C22H37NO2•HCl5 mg
  • WWL70
    A selective inhibitor of α/β-Hydrolase domain 6.1
    Katalog #CAS NummerSummenformelMenge
    sc-222420947669-91-2C27H23N3O31 mg/5 mg